Summary
McKesson Corporation's 10-Q filing for the period ending December 30, 1995, reveals a company actively engaged in its core pharmaceutical distribution business. While specific financial figures like revenue, net income, and balance sheet details are not directly present in the provided text snippet, the filing's existence indicates ongoing operational activity and compliance with SEC reporting requirements. Investors should look to the full document for details on the company's financial performance, any significant business developments, or strategic initiatives undertaken during this quarter. This filing serves as a snapshot of McKesson's financial health and operational status in late 1995. Investors interested in McKesson during this period would need to access the complete 10-Q to understand the quarter's results, including any expansion efforts, market challenges, or changes in inventory management and distribution networks that could impact future profitability and stock value. The absence of detailed financial data in this excerpt necessitates a deeper dive into the actual filing.
Key Highlights
- 1McKesson Corporation filed a 10-Q report for the quarter ending December 30, 1995.
- 2The filing date was February 12, 1996.
- 3The report is a standard quarterly filing, indicating ongoing operational activity.
- 4The provided text is an index/directory listing, not the full financial report.
- 5Investors need to access the full 10-Q filing for specific financial data and operational insights.
- 6This filing pertains to a period in the mid-1990s, reflecting the company's status at that time.